Loading…

High-sensitivity analysis of clonal hematopoiesis reveals increased clonal complexity of potential-driver mutations in severe COVID-19 patients

Whether Clonal Hematopoiesis (CH) represents a risk factor for severity of the COVID-19 disease remains a controversial issue. We report the first high- sensitivity analysis of CH in COVID-19 patients (threshold of detection at 0.5% vs 1 or 2% in previous studies). We analyzed 24 patients admitted t...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2024-01, Vol.19 (1), p.e0282546-e0282546
Main Authors: Ronchini, Chiara, Caprioli, Chiara, Tunzi, Gianleo, D'Amico, Francesco Furio, Colombo, Emanuela, Giani, Marco, Foti, Giuseppe, Conconi, Donatella, Lavitrano, Marialuisa, Passerini, Rita, Pase, Luca, Capizzi, Silvio, Mastrilli, Fabrizio, Alcalay, Myriam, Orecchia, Roberto, Natoli, Gioacchino, Pelicci, Pier Giuseppe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Whether Clonal Hematopoiesis (CH) represents a risk factor for severity of the COVID-19 disease remains a controversial issue. We report the first high- sensitivity analysis of CH in COVID-19 patients (threshold of detection at 0.5% vs 1 or 2% in previous studies). We analyzed 24 patients admitted to ICU for COVID-19 (COV-ICU) and 19 controls, including healthy subjects and asymptomatic SARS-CoV2-positive individuals. Despite the significantly higher numbers of CH mutations identified (80% mutations with
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0282546